Alerts will be sent to your verified email
Verify EmailBLISSGVS
Bliss GVS Pharma
|
Lincoln Pharma
|
Jagsonpal Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
2.57 % | 1.93 % | n/a |
Financials
|
|||
5 yr Average ROE
|
7.87 % | 15.94 % | 12.82 % |
5yr average Equity Multiplier
|
1.33 | 1.3 | 1.29 |
5yr Average Asset Turnover Ratio
|
0.63 | 0.84 | 1.12 |
5yr Avg Net Profit Margin
|
9.44 % | 14.61 % | 8.95 % |
Price to Book
|
1.32 | 1.88 | 8.06 |
P/E
|
22.33 | 13.45 | 30.37 |
5yr Avg Cash Conversion Cycle
|
169.17 Days | 24.49 Days | -0.27 Days |
Inventory Days
|
51.37 Days | 42.89 Days | 47.66 Days |
Days Receivable
|
187.07 Days | 90.22 Days | 25.88 Days |
Days Payable
|
75.42 Days | 111.35 Days | 68.7 Days |
5yr Average Interest Coverage Ratio
|
15.0 | 58.2 | 56.07 |
5yr Avg ROCE
|
14.67 % | 20.48 % | 17.0 % |
5yr Avg Operating Profit Margin
|
17.43 % | 18.48 % | 10.5 % |
5 yr average Debt to Equity
|
0.13 | 0.0 | 0.02 |
5yr CAGR Net Profit
|
-4.95 % | 12.65 % | 23.34 % |
5yr Average Return on Assets
|
5.91 % | 12.28 % | 9.97 % |
Shareholdings
|
|||
Promoter Holding
|
35.29 % | 49.78 % | 67.78 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
2.15 % | 7.73 % | -0.93 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Bliss GVS Pharma
|
Lincoln Pharma
|
Jagsonpal Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|